Getinge (OTCMKTS:GNGBY) Reaches New 12-Month High – Should You Buy?

Getinge (OTCMKTS:GNGBY) hit a new 52-week high on Tuesday . The stock traded as high as $24.05 and last traded at $23.8450, with a volume of 1434 shares changing hands. The stock had previously closed at $23.54.

Wall Street Analyst Weigh In

Separately, Nordea Equity Research raised shares of Getinge from a “hold” rating to a “buy” rating in a report on Wednesday, October 22nd. One investment analyst has rated the stock with a Buy rating and one has issued a Hold rating to the company’s stock. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy”.

Getinge Stock Performance

The business’s 50-day moving average is $22.84 and its two-hundred day moving average is $21.86. The company has a debt-to-equity ratio of 0.31, a current ratio of 1.34 and a quick ratio of 0.80.

Getinge (OTCMKTS:GNGBY) last issued its quarterly earnings data on Tuesday, October 21st. The company reported $0.25 earnings per share (EPS) for the quarter. The firm had revenue of $864.74 million during the quarter. Getinge had a net margin of 5.77% and a return on equity of 10.64%.

About Getinge

Getinge AB is a global medical technology company that develops, manufactures and markets products and systems for hospitals and life sciences institutions. The company’s offerings focus on critical care, surgical workflows and infection control, aiming to improve clinical outcomes and operational efficiency. Getinge’s solutions support a range of applications from intensive care and cardiovascular treatments to sterile reprocessing of surgical instruments.

The company’s product portfolio includes sterilization and disinfection equipment, surgical tables and lights, ventilation systems, heart-lung machines and extracorporeal membrane oxygenation (ECMO) devices.